Characterization of Plasmin-Cleaved ANGPTL4
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Eli Lilly (United States)
Variable analysis
- Incubation of recombinant ANGPTL4/8 (200 nM) with tPA (0.2 nM) and plasminogen (200 nM) in Abnova assay buffer at 37 °C for 10 min
- Incubation of recombinant ANGPTL4/8 (100 nM) with cells expressing LPL for 1 h at 37 °C, followed by addition of tPA (10 nM) and plasminogen (30 nM) and further incubation for 30 min at 37 °C
- ANGPTL4 cleavage products
- Polyclonal anti-ANGPTL4 antibody covalently coupled to tosyl-activated magnetic beads used for immunoprecipitation of endogenous ANGPTL4 protein and enrichment of ANGPTL4 cleavage products
- Aprotinin (50 µM) used to quench the plasmin-generating reactions
- Immunoprecipitation of endogenous ANGPTL4 protein from pooled normal human serum
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!